ici 204,219 has been researched along with Chronic Illness in 13 studies
zafirlukast: a leukotriene D4 receptor antagonist
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blinded, placebo-controlled trial comparing cetirizine 10 mg daily in combination with zafirlukast 20 mg twice a day versus cetirizine 10 mg daily and placebo was conducted to determine whether subjects with chronic urticaria benefit from add-on therapy with a leukotriene-modifying agent." | 9.11 | The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. ( Bagenstose, SE; Bernstein, JA; Levin, L, 2004) |
| " Two hundred ninety-four patients > or =12 years old with asthma previously uncontrolled with beta-2-agonists alone were randomly assigned to treatment with low-dose inhaled fluticasone (88 microg twice daily) or oral zafirlukast (20 mg twice daily)." | 9.09 | A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma. ( Bleecker, ER; Kalberg, C; Nathan, RA, 2001) |
| "A double-blinded, placebo-controlled trial comparing cetirizine 10 mg daily in combination with zafirlukast 20 mg twice a day versus cetirizine 10 mg daily and placebo was conducted to determine whether subjects with chronic urticaria benefit from add-on therapy with a leukotriene-modifying agent." | 5.11 | The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. ( Bagenstose, SE; Bernstein, JA; Levin, L, 2004) |
| " Two hundred ninety-four patients > or =12 years old with asthma previously uncontrolled with beta-2-agonists alone were randomly assigned to treatment with low-dose inhaled fluticasone (88 microg twice daily) or oral zafirlukast (20 mg twice daily)." | 5.09 | A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma. ( Bleecker, ER; Kalberg, C; Nathan, RA, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reimers, A | 1 |
| Pichler, C | 1 |
| Helbling, A | 1 |
| Pichler, WJ | 1 |
| Yawalkar, N | 1 |
| Bagenstose, SE | 1 |
| Levin, L | 1 |
| Bernstein, JA | 1 |
| Goldmeier, D | 1 |
| Madden, P | 1 |
| McKenna, M | 1 |
| Tamm, N | 1 |
| Hendeles, L | 1 |
| Marshik, PL | 1 |
| Spector, S | 1 |
| Tan, RA | 1 |
| Bensch, G | 1 |
| Borish, L | 1 |
| Thien, FC | 1 |
| D'Urzo, AD | 1 |
| Chapman, KR | 1 |
| Dempsey, OJ | 1 |
| Asero, R | 1 |
| Tedeschi, A | 1 |
| Lorini, M | 1 |
| Nathan, RA | 1 |
| Bleecker, ER | 1 |
| Kalberg, C | 1 |
| Cates, C | 1 |
5 reviews available for ici 204,219 and Chronic Illness
| Article | Year |
|---|---|
Zafirlukast for chronic asthma: convenient and generally safe, but is it effective?
Topics: Anti-Asthmatic Agents; Asthma; Chronic Disease; Humans; Indoles; Leukotriene Antagonists; Phenylcarb | 1997 |
Leukotriene modifiers in chronic urticaria.
Topics: Acetates; Adolescent; Adult; Child; Chronic Disease; Cyclopropanes; Drug Evaluation; Drug Synergism; | 1999 |
Leukotriene-receptor antagonists. Role in asthma management.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Bronchial Spasm; Chronic Disease; | 2000 |
Leukotriene receptor antagonist therapy.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Asthma, Exercise-Induced; Chronic Disease; Cyclopropanes; H | 2000 |
Chronic asthma.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Asthma; Beclomethasone; Chronic Dis | 2001 |
4 trials available for ici 204,219 and Chronic Illness
| Article | Year |
|---|---|
Zafirlukast has no beneficial effects in the treatment of chronic urticaria.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cross-Over Studies; Double-Blind Method; Drug Administrati | 2002 |
The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results.
Topics: Adult; Autoantigens; Cetirizine; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagoni | 2004 |
Treatment of category III A prostatitis with zafirlukast: a randomized controlled feasibility study.
Topics: Adolescent; Adult; Chronic Disease; Double-Blind Method; Feasibility Studies; Humans; Indoles; Leuko | 2005 |
A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Androstadienes; Anti-Asthmatic Agents; Anti-Inf | 2001 |
4 other studies available for ici 204,219 and Chronic Illness
| Article | Year |
|---|---|
Zafirlukast for asthma.
Topics: Anti-Asthmatic Agents; Asthma; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship | 1996 |
Antileukotrienes in chronic urticaria.
Topics: Adult; Chronic Disease; Humans; Hydroxyurea; Indoles; Leukotriene Antagonists; Male; Phenylcarbamate | 1998 |
Leukotriene receptor antagonist drugs for asthma.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Chronic Disease; Cyclopropanes; Humans; Indoles; Leukotrien | 1999 |
Leukotriene receptor antagonists in chronic urticaria.
Topics: Acetates; Adult; Aged; Chronic Disease; Cyclopropanes; Female; Follow-Up Studies; Humans; Indoles; L | 2001 |